Divine Aleru, Microbiome Signatures Research Coordinator

This study shows that T-cell stimulation lowers GPX4 protection and shifts activated T cells toward ferroptosis. Ferroptosis vulnerability varies by subset and tracks with GPX4 expression. GPX4 inhibition weakens CAR-T killing and cytokine output, while ferroptosis inhibition restores function and improves antitumor activity.

This review explains how ferroptosis shapes tumor immunity. Tumor ferroptosis can boost antigen presentation and T-cell killing, but ferroptosis in immune cells weakens surveillance and therapy response. Key control points include GPX4, system Xc−, iron handling, and lipid peroxidation.

What was reviewed? This review explored the role of selenium in ferroptosis, focusing on its essential involvement through glutathione peroxidase 4 (GPX4), a key selenoenzyme that protects against lipid peroxidation and ferroptosis. It examines the dual role of selenium in regulating iron-dependent lipid peroxidation and the mechanisms through which selenium, via GPX4 and other selenoproteins, […]

This study demonstrates that GPX4 is essential for motor neuron survival, with its ablation in mice leading to rapid motor neuron degeneration and paralysis via ferroptosis. Vitamin E supplementation delays disease onset, highlighting the potential for ferroptosis inhibition in treating neurodegenerative diseases.

This study identifies GPX4 as essential for human erythroblast enucleation, independent of ferroptosis. The results show that lipid raft clustering and myosin phosphorylation, which are necessary for enucleation, are disrupted in GPX4-deficient cells, and cholesterol supplementation can partially restore enucleation efficiency.

What Was Studied? The research paper reviewed the roles of GPX4 (Glutathione Peroxidase 4) in cell death, particularly focusing on its function in ferroptosis, autophagy, and disease. GPX4, a key selenoenzyme, plays a pivotal role in mitigating lipid peroxidation, thus protecting cells from oxidative stress and various forms of regulated cell death (RCD). The study […]

This review explains why stopping membrane lipid peroxidation is the most reliable way to block ferroptosis. It compares endogenous defenses with synthetic inhibitors and shows that optimized radical-trapping antioxidants offer the strongest in vivo potential, while many upstream strategies remain less consistent across models.

This review explains how a gut bacterial tryptophan metabolite, IDA, can promote colorectal cancer by blocking ferroptosis through an AHR–ALDH1A3–FSP1–CoQ10 pathway. It reframes microbial metabolites as direct regulators of tumor cell death vulnerability, not just immune modifiers.

What was studied? This was an experimental mechanistic study that tested whether GPX4 is a central regulator of ferroptosis and whether chemically inducing GPX4 failure can selectively kill cancer cells and suppress tumor growth. The authors compared multiple ferroptosis-inducing small molecules and used metabolomics, chemoproteomics, and genetic modulation to map where these compounds converge. They […]

This review explains how ferroptosis, driven by iron dysregulation and lipid peroxidation, exacerbates neuronal injury in ischemic stroke. It evaluates therapeutic strategies like ferrostatin-1, liproxstatin-1, and iron chelation, highlighting FABP5 as a potential biomarker for monitoring ferroptosis in stroke.

This review explains how ferroptosis drives kidney injury through iron-dependent lipid peroxidation when GPX4- and FSP1-based defenses fail. It highlights proximal tubule vulnerability, links ferroptosis to ischemia–reperfusion and nephrotoxins, and summarizes anti-ferroptotic strategies that protect kidneys in models.

This review explains how lipid metabolism drives ferroptosis by shaping oxidation-prone membrane phospholipids and controlling iron-dependent lipid peroxidation. It highlights ACSL4 and LPCAT3 remodeling, GPX4 and system xc− defenses, and backup antioxidant pathways such as FSP1–CoQ10 and GCH1–BH4, with implications for cancer and tissue injury.

This review explains how ACSL enzymes reshape tumor fatty-acid use and control ferroptosis and cancer immunity. It contrasts ACSL4-driven polyunsaturated lipid remodeling that promotes ferroptosis with ACSL3-oleic acid programs that resist ferroptosis, and it links these pathways to immunotherapy response.

This review explains ferroptosis, an iron-driven, lipid peroxidation cell-death pathway linked to metabolism and redox balance. It highlights key control points such as system xc−, glutathione, GPX4, lipid remodeling, and iron handling, and it connects these mechanisms to cancer and tissue injury.

What was reviewed? This paper reviewed ferroptosis as a regulated, non-apoptotic form of cell death driven by iron-dependent lipid peroxidation, then mapped the main molecular “pressure points” that determine whether cells resist or enter ferroptosis. It focused on core chemistry (iron handling and lipid oxidation), the best-supported defense systems that stop membrane damage, and how […]

What was studied? This study defined and experimentally mapped a distinct form of regulated cell death that the authors named ferroptosis. They used the RAS-selective small molecule erastin to trigger this phenotype, then tested what conditions were required for death, what cellular damage accumulated first, and how this process differed from apoptosis, necrosis, and autophagy. […]

Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by social, communication, and behavioral challenges. It involves genetic and environmental factors, including microbiome imbalances which influence symptom severity and overall health.

Traditionally linked to genetic predispositions and environmental exposures, emerging evidence highlights the microbiome as a critical and underappreciated factor influencing breast cancer progression, immune response, and treatment outcomes.

Pelvic Inflammatory Disease (PID) is a complex interplay between pathogens, immune responses, and microbial communities. As research continues to uncover the microbiome’s role in reproductive health, microbiome-targeted interventions (MBTIs) such as probiotics, prebiotics, and transplants are redefining how we prevent and treat PID. This page dives deep into these innovations, offering a glimpse into the future of personalized, biologically informed women’s healthcare.

Postpartum depression (PPD) affects many new mothers, influencing emotional, mental, and physical well-being. The gut microbiome, hormones, diet, and exercise all play a significant role in the onset, severity, and management of PPD. Early intervention, including probiotics, dietary changes, and therapy, can effectively alleviate symptoms and improve maternal and child health outcomes.

Premenstrual Syndrome (PMS) involves physical and emotional symptoms linked to hormonal fluctuations. Recent research highlights the role of heavy metals and gut microbiome imbalances in worsening these symptoms. Lifestyle changes, microbiome-targeted therapies, and toxin reduction show promise in effective PMS management.

Colibactin is a microbiome-derived genotoxin produced by a subset of gut-associated bacteria that carry the pks (clb) biosynthetic gene cluster. Rather than acting like a classical acute toxin, colibactin is clinically relevant because it can chemically damage host DNA, creating lesions that are difficult to repair and that may leave persistent mutations if cells survive. In a microbiome systems context, colibactin is best understood as a functional output of specific bacterial metabolism that can intersect with host genome stability, particularly at the intestinal epithelial interface.

This study shows a selective small molecule can block colibactin production by inhibiting the activating enzyme ClbP. The inhibitor stops colibactin-linked DNA damage signals and DNA adduct formation in infected cells and remains effective in a fecal microbiome model without broad antibiotic effects.

This review explains how gut microbiota can guide cancer screening and treatment, focusing on colibactin-producing E. coli in colorectal cancer. It links pks-positive E. coli to DNA damage, mutational fingerprints, senescence, and immune changes, and it outlines ways to target colibactin activity.